Get started
R&G PHARMASTUDIESR&G PHARMASTUDIESR&G PHARMASTUDIES

R&G PHARMASTUDIES

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

301333 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. It offers drug clinical research and development full process services for pharmaceutical companies and scientific research institutions. Its business activities include clinical trial operation services, clinical trial site management services, biological sample testing services, data management and statistical analysis services, clinical trial consulting services, and clinical pharmacology services. The company was founded by Jie Wu and Shu Qi Li on August 22, 2008 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

301333 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company